Protein corona: Opportunities and challenges

International Journal of Biochemistry and Cell Biology

Volumn 75, Issue , 2016, Pages 143-147

  Zanganeh, Saeid ^a   Spitler, Ryan ^a   Erfanzadeh, Mohsen ^b   Alkilany, Alaaldin M ^c   Mahmoudi, Morteza ^d  

^a STANFORD UNIVERSITY   (United States)

^b University of Connecticut   (United States)

^c UNIVERSITY OF JORDAN   (Jordan)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Nanoparticles; Nanotoxicology; Protein corona; Targeting

Indexed keywords

NANOPARTICLE; PROTEIN CORONA;

ARTICLE; DRUG RELEASE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN FIBRILLATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; TOXICITY ASSAY; ANIMAL; CHEMISTRY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; DRUG LIBERATION; HUMANS; NANOPARTICLES; PROTEIN CORONA;

EID: 84958581230     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2016.01.005     Document Type: Article

References (50)

1. M. Azhdarzadeh, and et al. Nanotoxicology: advances and pitfalls in research methodology Nanomedicine (Lond) 10 2015 2931 2952 10.2217/nnm.15.130
2. M. Azhdarzadeh, and et al. Nanotoxicology: advances and pitfalls in research methodology Nanomedicine 10 2015 2931 2952
3. S. Behzadi, and et al. Protein corona change the drug release profile of nanocarriers: the "overlooked" factor at the nanobio interface Colloids Surf. B: Biointerfaces 123 2014 143 149 10.1016/j.colsurfb.2014.09.009
4. S. Behzadi, and et al. Protein corona change the drug release profile of nanocarriers: the "overlooked" factor at the nanobio interface Colloids Surf. B: Biointerfaces 123 2014 143 149
5. M.V. Berridge, P.M. Herst, and A.S. Tan Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction Biotechnol. Annu. Rev. 11 2005 127 152
6. F. Bertoli, and et al. Magnetic nanoparticles to recover cellular organelles and study the time resolved nanoparticle-cell interactome throughout uptake Small 10 2014 3307 3315 10.1002/smll.201303841
7. C. Cabaleiro-Lago, and et al. Inhibition of amyloid β protein fibrillation by polymeric nanoparticles J. Am. Chem. Soc. 130 2008 15437 15443
8. C. Cabaleiro-Lago, F. Quinlan-Pluck, I. Lynch, K.A. Dawson, and S. Linse Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation ACS Chem. Neurosci. 1 2010 279 287
9. G. Caracciolo, D. Caputo, D. Pozzi, V. Colapicchioni, and R. Coppola Size and charge of nanoparticles following incubation with human plasma of healthy and pancreatic cancer patients Colloid Surf. B 123 2014 673 678 10.1016/j.colsurfb.2014.10.008
10. G. Caracciolo, and et al. Lipid composition: a "key factor" for the rational manipulation of the liposome-protein corona by liposome design RSC Adv. 5 2015 5967 5975 10.1039/c4ra13335h
11. A. Cifuentes-Rius, H. de Puig, J.C. Kah, S. Borros, and K. Hamad-Schifferli Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release ACS Nano 7 2013 10066 10074 10.1021/nn404166q
12. M. Hadjidemetriou, and et al. In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles ACS Nano 9 2015 8142 8156 10.1021/acsnano.5b03300
13. M.J. Hajipour, and et al. Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide Nanoscale 7 2015 8978 8994 10.1039/C5NR00520E
14. M.J. Hajipour, and et al. Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide Nanoscale 7 2015 8978 8994 10.1039/c5nr00520e
15. K. Hamad-Schifferli Exploiting the novel properties of protein coronas: emerging applications in nanomedicine Nanomedicine (Lond) 10 2015 1663 1674 10.2217/nnm.15.6
16. X. Jiang, and et al. Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding J. R. Soc. Interface 7 Suppl. 1 2010 S5 S13 10.1098/rsif.2009.0272.focus
17. J.C. Kah, J. Chen, A. Zubieta, and K. Hamad-Schifferli Exploiting the protein corona around gold nanorods for loading and triggered release ACS Nano 6 2012 6730 6740 10.1021/nn301389c
18. J.C. Kah, and et al. Protein coronas on gold nanorods passivated with amphiphilic ligands affect cytotoxicity and cellular response to penicillin/streptomycin ACS Nano 8 2014 4608 4620 10.1021/nn5002886
19. P.M. Kelly, and et al. Mapping protein binding sites on the biomolecular corona of nanoparticles Nat. Nanotechnol. 10 2015 472 479 10.1038/nnano.2015.47
20. Z. Krpetic, S. Anguissola, D. Garry, P.M. Kelly, K.A. Dawson, and Nanomaterials: impact on cells and cell organelles Adv. Exp. Med. Biol. 811 2014 135 156 10.1007/978-94-017-8739-0-8
21. A. Lesniak, and et al. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells ACS Nano 6 2012 5845 5857 10.1021/nn300223w
22. A. Lesniak, and et al. Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency J. Am. Chem. Soc. 135 2013 1438 1444 10.1021/ja309812z
23. P. Maffre, and et al. Effects of surface functionalization on the adsorption of human serum albumin onto nanoparticles - a fluorescence correlation spectroscopy study Beilstein J. Nanotechnol. 5 2014 2036 2047 10.3762/bjnano.5.212
24. M. Mahmoudi, and et al. A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles Colloids Surf. B: Biointerfaces 75 2010 300 309
25. M. Mahmoudi, and et al. Protein-nanoparticle interactions: opportunities and challenges Chem. Rev. 111 2011 5610
26. M. Mahmoudi, H. Hofmann, B. Rothen-Rutishauser, and A. Petri-Fink Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles Chem. Rev. 112 2011 2323 2338
27. M. Mahmoudi, O. Akhavan, M. Ghavami, F. Rezaee, and S.M. Ghiasi A. Graphene oxide strongly inhibits amyloid beta fibrillation Nanoscale 4 2012 7322 7325
28. M. Mahmoudi, and et al. Temperature: the "ignored" factor at the NanoBio interface ACS Nano 7 2013 6555 6562 10.1021/nn305337c
29. M. Mahmoudi, and et al. The protein corona mediates the impact of nanomaterials and slows amyloid beta fibrillation Chembiochem 14 2013 568 572 10.1002/cbic.201300007
30. E. Mahon, A. Salvati, F. Baldelli Bombelli, I. Lynch, and K.A. Dawson Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery" J. Control. Release 161 2012 164 174 10.1016/j.jconrel.2012.04.009
31. D. Maiolo, P. Bergese, E. Mahon, K.A. Dawson, and M.P. Monopoli Surfactant titration of nanoparticle-protein corona Anal. Chem. 86 2014 12055 12063 10.1021/ac5027176
32. D. Maiolo, P. Del Pino, P. Metrangolo, W.J. Parak, and F. Baldelli Bombelli Nanomedicine delivery: does protein corona route to the target or off road? Nanomedicine (Lond) 10 2015 3231 3247 10.2217/nnm.15.163
33. H.Y. Mao, and et al. Graphene: promises, facts, opportunities, and challenges in nanomedicine Chem. Rev. 113 2013 3407 3424
34. S. Milani, F.B. Bombelli, A.S. Pitek, K.A. Dawson, and J. Radler Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona ACS Nano 6 2012 2532 2541 10.1021/nn204951s
35. S. Mirsadeghi, and et al. Protein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation process Nanoscale 7 2015 5004 5013 10.1039/c4nr06009a
36. V. Mirshafiee, R. Kim, S. Park, M. Mahmoudi, and M.L. Kraft Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake Biomaterials 75 2016 295 304 10.1016/j.biomaterials.2015.10.019
37. M.P. Monopoli, C. Åberg, A. Salvati, and K.A. Dawson Biomolecular coronas provide the biological identity of nanosized materials Nat. Nanotechnol. 7 2012 779 786
38. M.P. Monopoli, C. Aberg, A. Salvati, and K.A. Dawson Biomolecular coronas provide the biological identity of nanosized materials Nat. Nanotechnol. 7 2012 779 786 10.1038/nnano.2012.207
39. M.P. Monopoli, A.S. Pitek, I. Lynch, and K.A. Dawson Formation and characterization of the nanoparticle-protein corona Methods Mol. Biol. 1025 2013 137 155 10.1007/978-1-62703-462-3-11
40. D.F. Moyano, and et al. Fabrication of corona-free nanoparticles with tunable hydrophobicity ACS Nano 8 2014 6748 6755 10.1021/nn5006478
41. D.J. O'Connell, and et al. Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials Nanoscale 7 2015 15268 15276 10.1039/c5nr01970b
42. B. Pelaz, and et al. Surface functionalization of nanoparticles with polyethylene glycol: effects on protein adsorption and cellular uptake ACS Nano 9 2015 6996 7008 10.1021/acsnano.5b01326
43. S. Rocha, and et al. Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide Biophys. Chem. 137 2008 35 42
44. K. Saha, D.F. Moyano, and V.M. Rotello Protein coronas suppress the hemolytic activity of hydrophilic and hydrophobic nanoparticles Mater Horiz. 2014 2014 102 105 10.1039/C3MH00075C
45. A.A. Saie, M. Ray, M. Mahmoudi, and V.M. Rotello Engineering the nanoparticle-protein interface for cancer therapeutics Cancer Treat. Res. 166 2015 245 273 10.1007/978-3-319-16555-4-11
46. U. Sakulkhu, and et al. Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats Nanoscale 6 2014 11439 11450 10.1039/c4nr02793k
47. A. Salvati, and et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface Nat. Nanotechnol. 8 2013 137 143 10.1038/nnano.2012.237
48. S. Sharifi, and et al. Toxicity of nanomaterials Chem. Soc. Rev. 41 2012 2323 2343
49. F. Wang, and et al. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes Nanomedicine 9 2013 1159 1168 10.1016/j.nano.2013.04.010
50. K. Yokoyama, and D. Welchons The conjugation of amyloid beta protein on the gold colloidal nanoparticles' surfaces Nanotechnology 18 2007 105101